Personalized Assessment Through Genetic and Clinical Testing The PlexusDx Precision Peptide Genetic Test analyzes GLP1R (rs6923761), and MC4R (rs17782313) variants that relate to GLP-1 and related signaling pathways
Ozempic is primarily used for blood sugar regulation in type-2 diabetes All three treatments reduce and regulate appetite Clinical trials for Mounjaro resulted in 91% of people losing more than 5% of their body weight, compared to 84% with Wegovy
Aguirre-Rueda et al., 2015
Pattern 2: Step down to a lower dose For some patients particularly those who reached goal at the maximum dose a lower maintenance dose preserves most of the appetite suppression while reducing cost, side effects, and the burden of long-term use at maximum dose
It is important for us to use sterile equipment, follow clean procedures, and never reuse needles or mixing water
This structure removes the financial penalty for needing higher doses and aligns PlexusDx's incentives with your long-term success rather than encouraging rushed escalation